KLK3 and prostate cancer: Importantly, at this MTD of PSA-TG prodrug, growth of LNCaP prostate cancer xenografts in mice treated via SQ Alzet mini-pump for 4 weeks is completely inhibited without substantial host toxicity (Figure 7A), but has no effect on PSA non-producing renal carcinoma xenografts [58].